Interferon alfa-2a in recurrent metastatic hemangiopericytoma.
نویسندگان
چکیده
1. Webber BL, Parham DM, Drake LG, et al. Renal tumors in childhood. Pathol Ann Part 1992;1:191–232. 2. Murphy WM, Beckwith JB, Farrow GM. Tumors of the kidney, bladder and related urinary structures. In: Murphy WM, Beckwith JB, Farrow GM, editors. Atlas of tumor pathology, series 3, fascicle 11. Washington D.C.: Armed Forces Institute of Pathology, 1994. 3. Beckwith JB. Pediatric neoplastic disorders of the kidney. In: Sternberg SS, editor. Diagnostic surgical pathology. Raven Press; 1994. p 1741–1766. 4. Parham DM. Renal neoplasms. In: Parham DM, editor. Pediatric neoplasia: morphology and biology. Lippincott-Raven; 1996. p 33–64. 5. Charles AK, Vujanic GM, Berry PJ. Renal tumors of childhood. Histopathology 1998;32:293–309. 6. Zuppan CV, Beckwith JB, Luckey DW. Anaplasia in unilateral Wilms tumor: a report from the National Wilms Tumor Study Pathology Center. Hum Pathol 1988;19:1199–1299. 7. Faria P, Beckwith JB, Mishra K, et al. Focal versus diffuse anaplasia in Wilms tumor: new definitions with prognostic significance. A report from the National Wilms Tumor Study Group. Am J Surg Pathol 1996;20:909–920. 8. Argani P, Perlman EJ, Breslow NE, et al. Clear cell sarcoma of the kidney. Am J Surg Pathol 2000;24:4–18. 9. Delemarre JF, Sandstedt B, Harms D, et al. The new SIOP (Stockholm) working classification of renal tumors of childhood. International Society of Paediatric Oncology. Med Pediatr Oncol 1996;26:145– 146. 10. Boccon-Gibod LA. Pathological evaluation of renal tumors in children: International Society of Pediatric Oncology approach. Ped Dev Pathol 1998;1:243–248. 11. Zuppan CW. Handling and evaluation of pediatric renal tumors. Am J Clin Pathol 109:S31–S37. 12. Jenkins MC, Allibone EB, Berry PJ. Neuroglial tissue in partially cystic Wilms tumour. Histopathology 1991;18:309–313. 13. Magee F, Mah RG, Taylor GP, et al. Neural differentiation in Wilms tumor. Hum Pathol 1987;18:33–37. 14. Brough AJ. Mesoblastic nephroma. Pediatr Pathol 1993;13:885–886. 15. Argani P, Beckwith JB. Metanephric stromal tumor. Report of 31 cases of a distinctive pediatric renal neoplasm. Am J Surg Pathol 2000;24:917– 926. 16. Variend S, Spicer RD, McKinnon AE. Teratoid Wilms tumour. Cancer 1984;53:1936–1942. 17. Vujanic GM. Teratoid Wilms Tumor. Pediatr Pathol 1991;11:303–309. 18. Magee JF, Ansari S, McFadden DE, et al. Teratoid Wilms tumour: a report of two cases. Histopathology 1992;20:427–431.
منابع مشابه
Safety and Efficacy of Pegylated Interferon Alfa-2a for the Treatment of Hepatitis C in Patients with Major Thalassemia
Background: Hepatitis C virus (HCV) infection is the most common transfusion transmitted disease in poly-transfused patients worldwide. In this study we aimed to evaluate the effects of pegylated interferon alfa-2a (PEG-IFN A-2a) in reducing serum ALT and eradicating serum hepatitis C virus (HCV) RNA in HCV infected polytransfused thalassemic patients. Materials and Methods: A cohort of 51 HCV-...
متن کاملInterferon alfa-2a versus combination therapy with interferon alfa-2a, interleukin-2, and fluorouracil in patients with untreated metastatic renal cell carcinoma (MRC RE04/EORTC GU 30012): an open-label randomised trial
BACKGROUND In metastatic renal cell carcinoma combinations of interferon alfa-2a, interleukin-2, and fluorouracil produce higher response rates and longer progression-free survival than do single agents. We aimed to compare overall survival in patients receiving combination treatment or interferon alfa-2a. METHODS RE04/30012 was an open-label randomised trial undertaken in 50 centres across e...
متن کاملSevere muscle weakness during treatment with pegylated interferon alfa for chronic hepatitis C virus infection A rare complication
Background: Interferons (IFNs) are common therapeutics for several diseases such as viral hepatitis, multiple sclerosis and malignancy. A variety of autoimmune related side effects have been observed during IFN therapy. Rare cases of myopathy, polymyositis or dermatomyositis have been reported during therapy with high doses of IFN^5. Case Presentation: In this report, we describe a case with se...
متن کاملBevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trial.
BACKGROUND Vascular endothelial growth factor (VEGF) inhibition is a valid therapeutic approach in renal cell carcinoma. Therefore, an investigation of the combination treatment of the humanised anti-VEGF monoclonal antibody bevacizumab with interferon alfa was warranted. METHODS In a multicentre, randomised, double-blind, phase III trial, 649 patients with previously untreated metastatic ren...
متن کاملEffect of peginterferon alfa-2a on liver histology in chronic hepatitis C: a meta-analysis of individual patient data.
Multicenter randomized trials have shown that once-weekly pegylated interferon (peginterferon) alfa-2a is more efficacious than conventional interferon alfa-2a (IFN) in patients with chronic hepatitis C. We performed a meta-analysis of 1,013 previously untreated patients (from 3 randomized trials) with pretreatment and post-treatment liver biopsies to assess the differences between peginterfero...
متن کاملPeginterferon alfa-2a plus ribavirin for treating chronic hepatitis C virus infection: analysis of Mexican patients included in a multicenter international clinical trial.
Treatment with polyethylene glycol-modified interferon alfa-2a (peginterferon) alone produces significantly higher sustained antiviral responses than treatment with interferon alfa-2a alone in patients with chronic hepatitis C virus (HCV) infection. We compared the efficacy and safety of peginterferon alfa-2a plus ribavirin, interferon alfa-2b plus ribavirin, and peginterferon alfa-2a alone in ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- Medical and pediatric oncology
دوره 40 3 شماره
صفحات -
تاریخ انتشار 2003